Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats

H. Zhang, E. Kandil, Y. Y. Lin, G. Levi, M. E. Zenilman

Research output: Contribution to journalArticle

Abstract

Background: Pancreatitis-associated protein (PAP) is a secretory protein not normally expressed in healthy pancreas but highly induced during acute pancreatitis. While PAP has been shown to be anti-bacterial and anti-apoptotic in vitro, its definitive biological function in vivo is not clear. Methods: To elucidate the function of PAP, antisense oligodeoxyribonucleotides (AS-PAP) targeting all three isoforms of PAP were administered via intrapancreatic injections (5 mg kg-1 day-1, 2 days) to rats prior to induction of pancreatitis. Results: Severity of pancreatitis and cytokine gene expression in peripheral blood mononuclear cells (PBMC) were evaluated. Administration of AS-PAP, but not the scrambled oligodeoxyribonucleotide (SC-PAP) control, reduced pancreatitis-induced PAP expression by 55.2 ± 6.4%, 44.0 ± 8.9%, and 38.9 ± 10.7% for PAP isoforms I, II, and III, respectively, compared to saline-treated controls (P <0.05 for all). Inhibition of PAP expression significantly worsened pancreatitis: serum amylase activity, pancreas wet weight (reflecting edema), and serum C-reactive protein levels all increased in AS-PAP-treated animals compared to SC-PAP-treated controls (by 3.5-, 1.7-, and 1.7-fold, respectively; P <0.05 for all). Histopathologic evaluation of pancreas revealed worsened edema, elevated leukocyte infiltration, and fat necrosis after AS-PAP treatment. Gene expressions of IL-1 μm and IL-4 were significantly higher in PBMC isolated from AS-PAP-treated rats compared to SC-PAP controls. Conclusion: This is the first in vivo evidence indicating that PAP mediates significant protection against pancreatic injury. Our data suggest that PAP may exert its protective function by suppressing local pancreatic as well as systemic inflammation during acute pancreatitis.

Original languageEnglish (US)
Pages (from-to)870-881
Number of pages12
JournalScandinavian Journal of Gastroenterology
Volume39
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Pancreatitis
Gene Expression
Pancreas
pancreatitis-associated protein
Edema
Blood Cells
Protein Isoforms
Antisense Oligodeoxyribonucleotides
Fat Necrosis
Oligodeoxyribonucleotides
Protein Transport
Amylases
Interleukin-1
Interleukin-4
C-Reactive Protein
Blood Proteins

Keywords

  • Acute pancreatitis
  • Antisense
  • Pancreatitis-associated protein

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats. / Zhang, H.; Kandil, E.; Lin, Y. Y.; Levi, G.; Zenilman, M. E.

In: Scandinavian Journal of Gastroenterology, Vol. 39, No. 9, 09.2004, p. 870-881.

Research output: Contribution to journalArticle

@article{a4e3b87bc38447d3af35fb2c8435bdf0,
title = "Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats",
abstract = "Background: Pancreatitis-associated protein (PAP) is a secretory protein not normally expressed in healthy pancreas but highly induced during acute pancreatitis. While PAP has been shown to be anti-bacterial and anti-apoptotic in vitro, its definitive biological function in vivo is not clear. Methods: To elucidate the function of PAP, antisense oligodeoxyribonucleotides (AS-PAP) targeting all three isoforms of PAP were administered via intrapancreatic injections (5 mg kg-1 day-1, 2 days) to rats prior to induction of pancreatitis. Results: Severity of pancreatitis and cytokine gene expression in peripheral blood mononuclear cells (PBMC) were evaluated. Administration of AS-PAP, but not the scrambled oligodeoxyribonucleotide (SC-PAP) control, reduced pancreatitis-induced PAP expression by 55.2 ± 6.4{\%}, 44.0 ± 8.9{\%}, and 38.9 ± 10.7{\%} for PAP isoforms I, II, and III, respectively, compared to saline-treated controls (P <0.05 for all). Inhibition of PAP expression significantly worsened pancreatitis: serum amylase activity, pancreas wet weight (reflecting edema), and serum C-reactive protein levels all increased in AS-PAP-treated animals compared to SC-PAP-treated controls (by 3.5-, 1.7-, and 1.7-fold, respectively; P <0.05 for all). Histopathologic evaluation of pancreas revealed worsened edema, elevated leukocyte infiltration, and fat necrosis after AS-PAP treatment. Gene expressions of IL-1 μm and IL-4 were significantly higher in PBMC isolated from AS-PAP-treated rats compared to SC-PAP controls. Conclusion: This is the first in vivo evidence indicating that PAP mediates significant protection against pancreatic injury. Our data suggest that PAP may exert its protective function by suppressing local pancreatic as well as systemic inflammation during acute pancreatitis.",
keywords = "Acute pancreatitis, Antisense, Pancreatitis-associated protein",
author = "H. Zhang and E. Kandil and Lin, {Y. Y.} and G. Levi and Zenilman, {M. E.}",
year = "2004",
month = "9",
doi = "10.1080/00365520410006477",
language = "English (US)",
volume = "39",
pages = "870--881",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats

AU - Zhang, H.

AU - Kandil, E.

AU - Lin, Y. Y.

AU - Levi, G.

AU - Zenilman, M. E.

PY - 2004/9

Y1 - 2004/9

N2 - Background: Pancreatitis-associated protein (PAP) is a secretory protein not normally expressed in healthy pancreas but highly induced during acute pancreatitis. While PAP has been shown to be anti-bacterial and anti-apoptotic in vitro, its definitive biological function in vivo is not clear. Methods: To elucidate the function of PAP, antisense oligodeoxyribonucleotides (AS-PAP) targeting all three isoforms of PAP were administered via intrapancreatic injections (5 mg kg-1 day-1, 2 days) to rats prior to induction of pancreatitis. Results: Severity of pancreatitis and cytokine gene expression in peripheral blood mononuclear cells (PBMC) were evaluated. Administration of AS-PAP, but not the scrambled oligodeoxyribonucleotide (SC-PAP) control, reduced pancreatitis-induced PAP expression by 55.2 ± 6.4%, 44.0 ± 8.9%, and 38.9 ± 10.7% for PAP isoforms I, II, and III, respectively, compared to saline-treated controls (P <0.05 for all). Inhibition of PAP expression significantly worsened pancreatitis: serum amylase activity, pancreas wet weight (reflecting edema), and serum C-reactive protein levels all increased in AS-PAP-treated animals compared to SC-PAP-treated controls (by 3.5-, 1.7-, and 1.7-fold, respectively; P <0.05 for all). Histopathologic evaluation of pancreas revealed worsened edema, elevated leukocyte infiltration, and fat necrosis after AS-PAP treatment. Gene expressions of IL-1 μm and IL-4 were significantly higher in PBMC isolated from AS-PAP-treated rats compared to SC-PAP controls. Conclusion: This is the first in vivo evidence indicating that PAP mediates significant protection against pancreatic injury. Our data suggest that PAP may exert its protective function by suppressing local pancreatic as well as systemic inflammation during acute pancreatitis.

AB - Background: Pancreatitis-associated protein (PAP) is a secretory protein not normally expressed in healthy pancreas but highly induced during acute pancreatitis. While PAP has been shown to be anti-bacterial and anti-apoptotic in vitro, its definitive biological function in vivo is not clear. Methods: To elucidate the function of PAP, antisense oligodeoxyribonucleotides (AS-PAP) targeting all three isoforms of PAP were administered via intrapancreatic injections (5 mg kg-1 day-1, 2 days) to rats prior to induction of pancreatitis. Results: Severity of pancreatitis and cytokine gene expression in peripheral blood mononuclear cells (PBMC) were evaluated. Administration of AS-PAP, but not the scrambled oligodeoxyribonucleotide (SC-PAP) control, reduced pancreatitis-induced PAP expression by 55.2 ± 6.4%, 44.0 ± 8.9%, and 38.9 ± 10.7% for PAP isoforms I, II, and III, respectively, compared to saline-treated controls (P <0.05 for all). Inhibition of PAP expression significantly worsened pancreatitis: serum amylase activity, pancreas wet weight (reflecting edema), and serum C-reactive protein levels all increased in AS-PAP-treated animals compared to SC-PAP-treated controls (by 3.5-, 1.7-, and 1.7-fold, respectively; P <0.05 for all). Histopathologic evaluation of pancreas revealed worsened edema, elevated leukocyte infiltration, and fat necrosis after AS-PAP treatment. Gene expressions of IL-1 μm and IL-4 were significantly higher in PBMC isolated from AS-PAP-treated rats compared to SC-PAP controls. Conclusion: This is the first in vivo evidence indicating that PAP mediates significant protection against pancreatic injury. Our data suggest that PAP may exert its protective function by suppressing local pancreatic as well as systemic inflammation during acute pancreatitis.

KW - Acute pancreatitis

KW - Antisense

KW - Pancreatitis-associated protein

UR - http://www.scopus.com/inward/record.url?scp=4544289943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544289943&partnerID=8YFLogxK

U2 - 10.1080/00365520410006477

DO - 10.1080/00365520410006477

M3 - Article

VL - 39

SP - 870

EP - 881

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 9

ER -